Skip to main content

Table 4 Pill burden from each drug category

From: Prescription characteristics of phosphate binders in a high pill burden for hemodialysis patients

Categories of oral drugs
(35 different types)
Pill burden and number of prescribed patients
Total pills Patients Patients Daily pills
(%) (n) (%) (pills/day/patient)
1 Phosphate binders 32.84 409 76.7 6.44
 Ca carbonate 16.37 301 56.5 4.36
 La carbonate 8.14 164 30.8 3.98
 Fe-based PBs 5.37 104 19.5 4.14
 Polymeric PBs 2.97 39 7.3 6.10
2 Antihypertensives 8.36 329 61.7 2.04
3 Coronary vasodilators, antianginal agents 8.12 308 57.8 2.12
4 Anticoagulants 6.06 269 50.5 1.81
5 Agents for peptic ulcer 5.52 307 57.6 1.44
6 Antidiabetic agents 4.95 175 32.8 2.27
7 Purgatives and clysters 3.47 153 28.7 1.82
8 Antidiarrheals, intestinal regulators 2.82 94 17.6 2.40
9 Agents for hyperlipidemias 2.48 189 35.5 1.05
10 Potassium binders 2.33 98 18.4 1.90
11 Calcimimetics 2.30 155 29.1 1.18
12 Antiarrhythmic agents 2.00 93 17.4 1.72
13 Hypnotics and sedatives, antianxietics 1.98 138 25.9 1.15
14 Vitamin D receptor activator (VDRA) 1.72 141 26.5 0.98
15 Diuretics 1.67 118 22.1 1.13
16 Antipyretics, analgesics and 1.46 83 15.6 1.41
 anti-inflammatory agents     
17 Antiallergic agents 1.16 94 17.6 0.99
18 Vitamin preparations (exc. VDRA) 1.16 36 6.8 2.59
19 Chinese medicines 1.04 76 14.3 1.10
20 Cholagogues 0.78 18 3.4 3.47
21 Antihypotensive agents 0.71 91 17.1 0.63
22 Antitussives and expectorants 0.58 35 6.6 1.32
23 Anti-itchings 0.56 34 6.4 1.33
24 Antidysuria agents 0.56 30 5.6 1.51
25 Gastrointestinal prokinetic agents 0.56 25 4.7 1.79
26 Psychotropic agents 0.54 28 5.3 1.54
27 Agents for treatment of gout 0.50 43 8.1 0.93
28 Antiepileptics 0.42 20 3.8 1.70
29 Thyroid preparations 0.41 26 4.9 1.28
30 Adrenal hormone preparations 0.35 17 3.2 1.65
31 Pain relieving agents 0.32 24 4.5 1.06
32 Zinc preparations 0.27 18 3.4 1.19
33 Antimicrobials 0.12 19 3.6 0.52
34 Agents used for common cold 0.12 18 3.4 0.53
35 Others (less than 10 prescribed-patients) 1.77 63 11.8 2.25
\